glp-1 coverage news The agency's “GLP-1 Bridge Program” will begin next month, allowing certain Medicare Part D enrollees to receive for select medications GLP-1 Coverage in Employer Plans

Discover current prescription statistics, usage trends, patient demographics, and access patterns for GLP-1 receptor agonists in the US healthcare system.

Discover FDA-approved timing guidance for liraglutide, semaglutide, and other GLP-1 medications, plus expert tips on managing side effects and improving adherence based on your daily routine.

The global obesity treatment market is expanding at unprecedented speed, with sales of weight-loss medications forecast to rise dramatically over the next decade.

Packaging and label may vary

This article reviews the efficacy and safety of different strategies to initiate and intensify basal insulin, with focus on new fixed ratio combinations of basal insulin with GLP-1 RAs available for use in a single injection pen (insulin degludec/liraglutide and insulin glargine/lixisenatide).